Predict your next investment

HEALTHCARE | Medical Facilities & Services / Specialized Healthcare Services
acuitymedical.com

See what CB Insights has to offer

Stage

Angel - III | Alive

Total Raised

$600K

Valuation

$0000 

Last Raised

$500K | 10 yrs ago

About Acuity Medical

Acuity Medical, Inc is a privately held medical sales and marketing organization based in Annapolis, Maryland.

Acuity Medical Headquarter Location

Annapolis, Massachusetts,

United States

Latest Acuity Medical News

Nova Oculus Gets Favorable Result in Legal Battle to Protect its Technology

Jul 11, 2018

An important judicial settlement in the legal fight to protect ground-breaking patents and intellectual property was reached last week by Nova Oculus Partners, LLC, the company developing a pioneering device to successfully treat the dry version of Age-Related Macular Degeneration. In September of last year, Nova Oculus filed suit in the U.S. District Court in Minnesota against Amerivision International Inc., and three of that company’s principals: Blair Mowery, Marshall Masko and John Jarding, alleging the defendants misappropriated tangible and intellectual property from another company, Acuity Medical International, that rightfully belongs to Nova Oculus. The suit, involving primarily allegations of trade secret misappropriation and breach of confidentiality obligations, has now been settled out of court. Acuity’s assets were purchased by Nova Oculus in a trustee bill of sale in 2015 as part of Acuity’s bankruptcy proceedings. The defendants were all principals of Acuity prior to its bankruptcy and formed Amerivision after Nova Oculus had purchased Acuity’s assets. As a result of the litigation, Amerivision has agreed to pay Nova Oculus a confidential amount in monetary damages. Amerivision has also corrected public misstatements it made regarding the existence and viability of its product. Specifically, Amerivision now acknowledges: (1) it has no product; (2) it has no product prototype; (3) it has no designs or technical specifications for a product or product prototype; (4) it has no product being manufactured; and (5) has no product in clinical trials . The case is Nova Oculus Partners, LLC et al. v. Amerivision International, Inc. et al., Case No. 17-4295 (PAM/SER), in the United States District Court for the District of Minnesota. Nova Oculus was represented in this action by Scott Eidson of the firm Stinson Leonard Street of St. Louis, MO. ABOUT NOVA OCULUS NOVA OCULUS IS THE NAME of the pioneering new medical device engineered and developed to treat the dry form of Age-Related Macular Degeneration—and for the company of talented and innovative people that created it. Our Nova Oculus device will revolutionize the treatment protocols for dry AMD and offer hope to millions of Americans who are going blind without it. Dry AMD is an affliction without a cure, yet our microcurrent electro-therapy technology is proving to successfully mitigate its symptoms. We have a blue-ribbon team of highly experienced engineering professionals leading our efforts to bring Nova Oculus to market. We have also assembled a medical advisory board that includes some of the leading optometric professionals in the United States, and we are developing a plan to earn FDA approval for the Nova Oculus and gain its widespread commercialization in the U.S. The Nova Oculus device has been certified as complying with the quality management standard set by the International Organization of Standardization (ISO) and the electrical safety standard set by the International Electrotechnical Commission (IEC). These certifications pave the way for global regulatory approvals for Nova Oculus. For more information:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.